ML Labs

79 days ago

Tom Winnifrith Bearcast No 1: An old dinosaur remembers ML Labs and its AIDS "cure" as I ponder an insane valuation and what Hemogenyx is NOT saying

Forgive my reminiscing back to, I think, 1995 or maybe 1996 but this is pertinent as I consider the valuaton of Hemogenyx (HEMO) and what Vlad Sandler is NOT telling us about his phase 1 trials.

524 days ago

Now really is a good time to short Avacta, its shareholder base is terribly naive

I started writing about biotech and emerging pharma stocks more than 30 years ago when I was at the Investors Chronicle. The army of PI cheerleaders for Avacta (AVCT) probably have not heard of British Biotech, a £2 billion blow up, of ML Labs a half a billion blow up. Almost thirty years ago I exposed both companies for the overvalued crocks they were and also for the way that they duped investors with misleading releases